- Home
- ABT
as 11-20-2025 3:36pm EST
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
| Founded: | 1888 | Country: | United States |
| Employees: | N/A | City: | ABBOTT PARK |
| Market Cap: | 231.5B | IPO Year: | N/A |
| Target Price: | $146.61 | AVG Volume (30 days): | 6.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 18 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 7.96 | EPS Growth: | 141.97 |
| 52 Week Low/High: | $110.86 - $141.23 | Next Earning Date: | 10-15-2025 |
| Revenue: | $43,843,000,000 | Revenue Growth: | 6.37% |
| Revenue Growth (this year): | 7.55% | Revenue Growth (next year): | 7.70% |
Latest Abbott Laboratories News
ABT Breaking Stock News: Dive into ABT Ticker-Specific Updates for Smart Investing
Yahoo Finance Video
17 hours ago
Abbott to buy Exact Sciences for $21B, Verizon to cut 13K jobs
Investor's Business Daily
17 hours ago
Exact Sciences Catapults On $23 Billion Abbott Labs Buyout
MT Newswires
17 hours ago
Sector Update: Health Care Stocks Edge Higher Premarket Thursday
MT Newswires
17 hours ago
Update: Abbott Laboratories to Acquire Exact Sciences for $21 Billion
MT Newswires
17 hours ago
Sector Update: Health Care
The Wall Street Journal
17 hours ago
Abbott to Acquire Exact Sciences for $21 Billion
Barrons.com
18 hours ago
Exact Sciences Stock Soars. Abbott Is Buying It in Deal Valued at $21 Billion.
Investing.com
18 hours ago
Exact Sciences stock jumps after Abbott confirms acquisition
Compare ABT vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ABT Abbott Laboratories - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.